AI assistant
NEOGENOMICS INC — Director's Dealing 2018
Aug 3, 2018
32227_dirs_2018-08-03_6e1a87e6-7409-452e-a2b7-6d800e2caa21.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2018-08-01
Reporting Person: VAN OORT DOUGLAS M (Director, Chairman and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-08-01 | Common Stock | A | 46429 | — | Acquired | 2054552 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 187500 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy | $7.15 | 2021-04-20 | Common Stock (472527.0) | 472527 | Direct |
| Stock Option (Right to Buy) | $7.52 | 2022-04-28 | Common Stock (500000.0) | 500000 | Direct |
| Stock Option (Right to Buy) | $8.03 | 2023-02-26 | Common Stock (500000.0) | 500000 | Direct |
Footnotes
F1: On August 1, 2018, Mr. VanOort was granted 46,429 shares of restricted stock. These shares vest ratably over the first three anniversary dates of the grant date.
F2: Conundrum Capital Partners, LLC is a limited liability partnership 50% owned by Mr. VanOort. Mr.VanOort is a managing partner of Conundrum Capital Partners, LLC.
F3: On April 20, 2016, Mr. VanOort was granted 472,527 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F4: On April 28, 2017, Mr. VanOort was granted 500,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F5: On February 26, 2018, Mr. VanOort was granted 500,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.